Featured Research

from universities, journals, and other organizations

New tuberculosis vaccine developed

Date:
October 1, 2013
Source:
McMaster University
Summary:
A new vaccine has been developed to act as a booster to Bacille Calmette Guerin (BCG), currently the only TB vaccine available. BCG was developed in the 1920s and has been used worldwide. The new “booster” would reactivate immune elements that over time diminish following BCG vaccination.

A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

Related Articles


"We are the first to have developed such a vaccine for tuberculosis," said Dr. Fiona Smaill, professor and chair of the Department of Pathology and Molecular Medicine of the Michael G. DeGroote School of Medicine at McMaster. She led the phase one clinical study published today in the journal Science Translational Medicine.

The vaccine, based on a genetically modified cold virus, was developed in the lab of Zhou Xing, professor of pathology and molecular medicine and the McMaster Immunology Research Centre, who co-led the phase one study. Both are also members of the Michael G. DeGroote Institute for Infectious Disease Research.

"Tuberculosis is a serious public health threat," Smaill said. "One-third of world's population is infected with the organism that causes tuberculosis, and it remains the top infectious killer of people only secondary to HIV; yet, the current vaccine used to prevent it is ineffective."

The control of tuberculosis (TB) has met with further challenge from high incidence of multi-drug resistant tuberculosis, she added.

The new vaccine was developed to act as a booster to Bacille Calmette Guerin (BCG), currently the only TB vaccine available. BCG was developed in the 1920s and has been used worldwide. The new "booster" would reactivate immune elements that over time diminish following BCG vaccination.

Currently the BCG vaccine is part of the World Health Organization's immunization program in Asia, Africa, Eastern Europe and South America, as well as Nunavut, the only Canadian jurisdiction where the BCG vaccine is routinely given because of the high rate of tuberculosis in the territory. It is typically given in the first year of life.

The McMaster vaccine has been more than a decade in the making. McMaster researchers began the first human clinical trial in 2009 with 24 healthy human volunteers, including 12 who were previously BCG-immunized.

"The primary goal was to look at the safety of a single dose vaccine injection," said Xing, "as well as its potency to engage the immune system."

By 2012 they established that the vaccine was safe and observed a robust immune response in most trial participants. More clinical trials are needed to measure the vaccine's real potential, Xing added.

Smaill added: "As a doctor who looks after patients who have tuberculosis, including those who are HIV infected, I realize how important it is going to be to control this infection with a good vaccine.

"We are probably one of a few groups in the world who are actually doing bench-to-human tuberculosis vaccine work, and we are excited to be part of this and thrilled that it started at McMaster."


Story Source:

The above story is based on materials provided by McMaster University. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. Smaill, M. Jeyanathan, M. Smieja, M. F. Medina, N. Thanthrige-Don, A. Zganiacz, C. Yin, A. Heriazon, D. Damjanovic, L. Puri, J. Hamid, F. Xie, R. Foley, J. Bramson, J. Gauldie, Z. Xing. A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine, 2013; 5 (205): 205ra134 DOI: 10.1126/scitranslmed.3006843

Cite This Page:

McMaster University. "New tuberculosis vaccine developed." ScienceDaily. ScienceDaily, 1 October 2013. <www.sciencedaily.com/releases/2013/10/131001151055.htm>.
McMaster University. (2013, October 1). New tuberculosis vaccine developed. ScienceDaily. Retrieved December 26, 2014 from www.sciencedaily.com/releases/2013/10/131001151055.htm
McMaster University. "New tuberculosis vaccine developed." ScienceDaily. www.sciencedaily.com/releases/2013/10/131001151055.htm (accessed December 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

FDA Issues New Warning About Pure Caffeine Powder Usage

FDA Issues New Warning About Pure Caffeine Powder Usage

Newsy (Dec. 24, 2014) The FDA cites two deaths this year linked to pure caffeine powder as warnings of the potentially fatal substance. Video provided by Newsy
Powered by NewsLook.com
Alarming CDC Lab Report Reveals Ebola Sample Mix-Up

Alarming CDC Lab Report Reveals Ebola Sample Mix-Up

Newsy (Dec. 24, 2014) The Centers for Disease Control and Prevention released a report claiming a lab tech in Atlanta might have been exposed to the Ebola virus. Video provided by Newsy
Powered by NewsLook.com
French General Physicians Begin Strike, ER Doctors Back to Work

French General Physicians Begin Strike, ER Doctors Back to Work

AFP (Dec. 23, 2014) French doctors went on strike Tuesday in protest at an upcoming health bill. Emergency room doctors on the other end are returning to work after reaching an historic agreement. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
Malpractice Suit Changes Rule for Cruise Ships

Malpractice Suit Changes Rule for Cruise Ships

AP (Dec. 23, 2014) A recent court ruling may have opened the courthouse door for cruise ship passengers who claim poor treatment by ship medical personnel. (Dec. 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins